Biggest News Aggregation in the World
📰 Nasdaq Pcvx News

Page 3 - Nasdaq Pcvx News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Nasdaq Pcvx. Real-time updates on events, politics, business and more.

Vaxcyte (NASDAQ:PCVX) Earns Buy Rating from Analysts at Mizuho

Mizuho initiated coverage on shares of Vaxcyte (NASDAQ:PCVX – Free Report) in a research report report published on Thursday, MarketBeat Ratings reports. The brokerage issued a buy rating and a $69.00 target price on the stock. Several other research firms have also recently commented on PCVX. Cantor Fitzgerald reiterated an overweight rating and set a […]
United States Andrew Guggenhime Zurcher Kantonalbank Zurich Cantonalbank Citigroup Inc Truist Financial Corp Cantor Fitzgerald

Harvest Investment Services LLC Acquires New Stake in Vaxcyte, Inc. (NASDAQ:PCVX)

Harvest Investment Services LLC acquired a new stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 13,810 shares of the company’s stock, valued at approximately $690,000. A number of other hedge funds […]
Jim Wassil Vaxcyte Inc Jpmorgan Chase Co Metlife Investment Management Groupa Streptococcus York Mellon Corp
Source: wkrb13.com

E Fund Management Co. Ltd. Sells 1,378 Shares of Vaxcyte, Inc. (NASDAQ:PCVX)

E Fund Management Co. Ltd. trimmed its stake in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 13.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 8,834 shares of the company’s stock after selling 1,378 shares during the period. E Fund Management Co. Ltd.’s […]
Jim Wassil Wells Fargo Company Groupa Streptococcus Fund Management Co Exchange Commission Russell Investments Group Ltd

Chicago Partners Investment Group LLC Sells 1,002 Shares of Vaxcyte, Inc. (NASDAQ:PCVX)

Chicago Partners Investment Group LLC trimmed its position in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 14.0% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,157 shares of the company’s stock after selling 1,002 shares during the period. Chicago Partners […]
United States Mikhail Eydelman Jim Wassil Securities Exchange Commission Groupa Streptococcus Vanguard Group Inc

Cantor Fitzgerald Analysts Reduce Earnings Estimates for Vaxcyte, Inc. (NASDAQ:PCVX)

Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) – Equities research analysts at Cantor Fitzgerald reduced their FY2023 earnings estimates for Vaxcyte in a research note issued on Tuesday, November 7th. Cantor Fitzgerald analyst L. Chen now expects that the company will earn ($3.33) per share for the year, down from their previous estimate of ($3.05). Cantor […]
Jim Wassil Securities Exchange Commission York Mellon Corp Swiss National Bank Groupa Streptococcus Metlife Investment Management

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Vaxcyte (NASDAQ:PCVX) Announces Earnings Results

Vaxcyte (NASDAQ:PCVX – Get Free Report) issued its earnings results on Monday. The company reported ($0.91) earnings per share for the quarter, missing the consensus estimate of ($0.84) by ($0.07), Briefing.com reports. Vaxcyte Stock Up 0.7 % Shares of Vaxcyte stock opened at $50.60 on Thursday. Vaxcyte has a 12-month low of $34.11 and a […]
United States Jim Wassil Vaxcyte Company Profile Osaic Holdings Inc Nuveen Asset Management Cantor Fitzgerald

Moody Aldrich Partners LLC Makes New $1.23 Million Investment in Vaxcyte, Inc. (NASDAQ:PCVX)

Moody Aldrich Partners LLC purchased a new position in shares of Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) during the second quarter, Holdings Channel.com reports. The fund purchased 24,665 shares of the company’s stock, valued at approximately $1,232,000. Other hedge funds and other institutional investors also recently made changes to their positions in the company. ETF […]
United States Jim Wassil Zurcher Kantonalbank Zurich Cantonalbank Citigroup Inc Vaxcyte Company Profile Managers Group
Source: wkrb13.com

Brokerages Set Vaxcyte, Inc. (NASDAQ:PCVX) PT at $65.00

Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) has been given a consensus rating of “Buy” by the six research firms that are presently covering the firm, Marketbeat Ratings reports. Six analysts have rated the stock with a buy recommendation. The average 1-year target price among brokers that have issued ratings on the stock in the […]
Mikhail Eydelman Jim Wassil Groupa Streptococcus Cantor Fitzgerald Needham Company Vaxcyte Inc
Source: wkrb13.com

Insider Selling: Vaxcyte, Inc. (NASDAQ:PCVX) CEO Sells 15,000 Shares of Stock

Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) CEO Grant Pickering sold 15,000 shares of Vaxcyte stock in a transaction that occurred on Monday, September 25th. The shares were sold at an average price of $52.45, for a total value of $786,750.00. Following the sale, the chief executive officer now directly owns 400,914 shares in the […]
Cantor Fitzgerald Securities Exchange Commission Needham Company Carlyle Group Inc Blackrock Inc Vaxcyte Inc

Reviewing Adaptimmune Therapeutics (NASDAQ:ADAP) and Vaxcyte (NASDAQ:PCVX)

Vaxcyte (NASDAQ:PCVX – Get Free Report) and Adaptimmune Therapeutics (NASDAQ:ADAP – Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, dividends, valuation, profitability, institutional ownership, risk and analyst recommendations. Analyst Recommendations This is a breakdown of current ratings […]
United States San Carlos United Kingdom Sutrovax Inc Alpine Immune Sciences Genentech Inc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science